Genomic Health Company Profile (NASDAQ:GHDX)

About Genomic Health

Genomic Health logoGenomic Health, Inc. is a healthcare company, which provides genomic-based diagnostic tests for the treatment of early stage cancer. The Company offers its Oncotype DX tests as a clinical laboratory service, where it analyzes the expression levels of genes in tumor tissue samples and provides physicians with a quantitative gene expression profile expressed as a single quantitative score, which it calls a Recurrence Score for invasive breast cancer and colon cancer, a DCIS Score for ductal carcinoma in situ (DCIS) and a Genomic Prostate Score for prostate cancer. Its Oncotype DX tests utilizes quantitative genomic analysis known as reverse transcription polymerase chain reaction, in standard tumor pathology specimens to provide tumor-specific information, or the oncotype of a tumor. It offers its services and products, including Oncotype DX Breast Cancer Test, Oncotype DX Colon Cancer Test and Oncotype DX Prostate Cancer Test through its Oncotype IQ Genomic Intelligence Platform.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: GHDX
  • CUSIP: 37244C10
Key Metrics:
  • Previous Close: $26.29
  • 50 Day Moving Average: $28.02
  • 200 Day Moving Average: $26.58
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 328.63
  • P/E Growth: -10.24
  • Market Cap: $876.67M
  • Outstanding Shares: 33,346,000
  • Beta: 0.5
Additional Links:
Companies Related to Genomic Health:

Analyst Ratings

Consensus Ratings for Genomic Health (NASDAQ:GHDX) (?)
Ratings Breakdown: 2 Sell Ratings, 2 Hold Ratings, 5 Buy Ratings
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $32.44 (23.41% upside)

Analysts' Ratings History for Genomic Health (NASDAQ:GHDX)
DateFirmActionRatingPrice TargetDetails
8/17/2016Jefferies GroupBoost Price TargetHold$25.00 -> $27.00View Rating Details
8/5/2016Canaccord GenuityReiterated RatingBuy$38.00View Rating Details
8/3/2016Bank of America Corp.Set Price TargetSell$28.00View Rating Details
6/21/2016Leerink SwannReiterated RatingBuyView Rating Details
2/11/2016Cowen and CompanyReiterated RatingBuyView Rating Details
2/11/2016Barclays PLCLower Price TargetUnderweight$27.00 -> $25.00View Rating Details
2/11/2016Piper Jaffray Cos.Reiterated RatingIn-Line$32.00 -> $31.00View Rating Details
11/4/2015Raymond James Financial Inc.UpgradeMarket Perform -> Outperform$29.00View Rating Details
11/2/2015JMP SecuritiesBoost Price TargetOutperform$34.00 -> $36.00View Rating Details
5/28/2015Credit Suisse Group AGReiterated RatingNeutralView Rating Details
2/11/2015William BlairReiterated RatingOutperformView Rating Details
12/19/2014Wells Fargo & Co.Initiated CoverageMarket PerformView Rating Details
(Data available from 8/24/2014 forward)


Earnings History for Genomic Health (NASDAQ:GHDX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2016Q216($0.18)($0.18)$81.27 million$81.97 millionViewN/AView Earnings Details
5/4/2016Q1($0.24)($0.19)$78.12 million$80.89 millionViewN/AView Earnings Details
2/10/2016Q415($0.09)($0.10)$74.03 million$74.50 millionViewListenView Earnings Details
11/3/2015Q315($0.18)($0.36)$73.35 million$73.60 millionViewN/AView Earnings Details
8/4/2015Q215($0.27)($0.29)$71.65 million$70.60 millionViewListenView Earnings Details
5/5/2015Q115($0.26)($0.30)$68.20 millionViewN/AView Earnings Details
2/10/2015Q414($0.22)($0.20)$72.20 million$69.10 millionViewN/AView Earnings Details
11/4/2014Q314($0.22)($0.20)$71.00 million$69.10 millionViewN/AView Earnings Details
8/5/2014Q214($0.26)($0.15)$69.04 million$70.50 millionViewN/AView Earnings Details
5/6/2014Q114($0.18)($0.24)$68.47 million$67.00 millionViewN/AView Earnings Details
2/4/2014Q413($0.03)($0.30)$69.20 million$68.80 millionViewN/AView Earnings Details
11/5/2013Q313($0.04)$0.02$64.98 million$65.99 millionViewN/AView Earnings Details
7/31/2013Q2 2013($0.08)($0.10)$63.91 million$63.70 millionViewN/AView Earnings Details
5/2/2013Q1 2013($0.02)($0.03)$62.90 million$63.10 millionViewN/AView Earnings Details
2/6/2013Q4 2012$0.03$0.06$58.90 million$60.40 millionViewN/AView Earnings Details
11/7/2012Q312$0.05$0.11$59.87 million$58.60 millionViewN/AView Earnings Details
8/8/2012($0.02)$0.06ViewN/AView Earnings Details
5/2/2012($0.02)$0.02ViewN/AView Earnings Details
2/6/2012$0.09$0.08ViewN/AView Earnings Details
11/1/2011$0.03$0.10ViewN/AView Earnings Details
8/3/2011$0.02$0.08ViewN/AView Earnings Details
5/3/2011$0.02($0.01)ViewN/AView Earnings Details
2/8/2011$0.06$0.06ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Genomic Health (NASDAQ:GHDX)
Current Year EPS Consensus Estimate: $-0.47 EPS
Next Year EPS Consensus Estimate: $0.08 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165($0.25)($0.07)($0.17)
Q2 20167($0.20)($0.01)($0.11)
Q3 20165($0.15)$0.01($0.05)
Q4 20167($0.02)$0.04$0.01
Q1 20171$0.01$0.01$0.01
Q2 20171$0.01$0.01$0.01
Q3 20171$0.01$0.01$0.01
Q4 20171$0.01$0.01$0.01
(Data provided by Zacks Investment Research)


Dividend History for Genomic Health (NASDAQ:GHDX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Genomic Health (NASDAQ:GHDX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/15/2016Felix BakerDirectorBuy100,000$27.02$2,702,000.00View SEC Filing  
8/11/2016G Bradley ColeCOOSell5,000$28.87$144,350.00View SEC Filing  
8/8/2016James J. VaughnInsiderSell3,000$28.74$86,220.00View SEC Filing  
7/19/2016Steven ShakInsiderSell5,000$27.42$137,100.00View SEC Filing  
7/6/2016G Bradley ColeCOOSell5,000$26.64$133,200.00View SEC Filing  
6/21/2016Steven ShakInsiderSell5,000$25.77$128,850.00View SEC Filing  
6/9/2016G Bradley ColeCOOSell5,000$26.62$133,100.00View SEC Filing  
6/6/2016James J VaughnInsiderSell1,997$28.00$55,916.00View SEC Filing  
5/16/2016G Bradley ColeCOOSell5,000$27.60$138,000.00View SEC Filing  
5/10/2016Phillip G FebboInsiderSell6,324$27.20$172,012.80View SEC Filing  
5/4/2016Steven ShakInsiderSell10,000$25.43$254,300.00View SEC Filing  
1/13/2016Randall S. LivingstonDirectorSell1,250$32.14$40,175.00View SEC Filing  
1/12/2016G Bradley ColeCOOSell4,000$31.69$126,760.00View SEC Filing  
1/7/2016James J. VaughninsiderSell2,000$33.63$67,260.00View SEC Filing  
12/8/2015G Bradley ColeCOOSell4,000$29.26$117,040.00View SEC Filing  
12/7/2015James J. VaughninsiderSell2,000$29.33$58,660.00View SEC Filing  
11/10/2015G Bradley ColeCOOSell4,000$26.03$104,120.00View SEC Filing  
9/9/2015G Bradley ColeCOOSell9,664$25.35$244,982.40View SEC Filing  
7/7/2015G Bradley ColeCOOSell4,000$27.53$110,120.00View SEC Filing  
6/9/2015G Bradley ColeCOOSell4,000$26.24$104,960.00View SEC Filing  
4/13/2015Kimberly J PopovitsCEOSell3,000$31.28$93,840.00View SEC Filing  
4/7/2015G Bradley ColeCOOSell4,000$30.44$121,760.00View SEC Filing  
2/2/2015Randall S LivingstonDirectorSell1,000$31.93$31,930.00View SEC Filing  
1/12/2015Kimberly J PopovitsCEOSell3,000$33.46$100,380.00View SEC Filing  
12/8/2014G Bradley ColeCOOSell4,336$32.52$141,006.72View SEC Filing  
11/12/2014Kimberly J PopovitsCEOSell4,300$34.82$149,726.00View SEC Filing  
10/13/2014Kimberly J PopovitsCEOSell3,000$30.78$92,340.00View SEC Filing  
10/8/2014G Bradley ColeCOOSell4,000$28.77$115,080.00View SEC Filing  
9/11/2014Kimberly J PopovitsCEOSell3,000$29.82$89,460.00View SEC Filing  
9/8/2014G Bradley ColeCOOSell4,700$30.09$141,423.00View SEC Filing  
8/14/2014Steven ShakEVPSell13,348$27.36$365,201.28View SEC Filing  
8/13/2014Steven ShakEVPSell7,000$27.25$190,750.00View SEC Filing  
7/14/2014Kimberly J PopovitsCEOSell3,000$26.59$79,770.00View SEC Filing  
7/8/2014G Bradley ColeCOOSell2,300$27.05$62,215.00View SEC Filing  
7/1/2014Steven ShakEVPSell7,000$27.00$189,000.00View SEC Filing  
4/14/2014Steven ShakEVPSell7,000$26.25$183,750.00View SEC Filing  
4/8/2014G Bradley ColeCOOSell3,000$27.00$81,000.00View SEC Filing  
3/14/2014Steven ShakEVPSell7,000$28.36$198,520.00View SEC Filing  
2/18/2014Kathy HibbsSVPSell1,312$27.88$36,578.56View SEC Filing  
1/15/2014Steven ShakEVPSell7,000$31.51$220,570.00View SEC Filing  
1/13/2014Kimberly PopovitsCEOSell2,500$30.00$75,000.00View SEC Filing  
12/17/2013Steven ShakCMOSell14,000$29.57$413,980.00View SEC Filing  
12/12/2013Kimberly PopovitsCEOSell2,500$30.68$76,700.00View SEC Filing  
12/9/2013Dean SchornoCFOSell3,000$33.25$99,750.00View SEC Filing  
10/15/2013Steven ShakCMOSell5,000$29.67$148,350.00View SEC Filing  
10/10/2013Kimberly PopovitsCEOSell2,500$30.00$75,000.00View SEC Filing  
10/9/2013G Bradley ColeCOOSell2,500$29.95$74,875.00View SEC Filing  
9/18/2013Steven ShakCMOSell5,000$33.73$168,650.00View SEC Filing  
9/12/2013Kimberly PopovitsCEOSell2,500$34.31$85,775.00View SEC Filing  
9/9/2013G Bradley ColeCOOSell2,500$32.53$81,325.00View SEC Filing  
9/6/2013Dean L SchornoCFOSell4,000$32.90$131,600.00View SEC Filing  
9/3/2013Randall LivingstonDirectorSell1,000$31.49$31,490.00View SEC Filing  
8/14/2013Steven ShakCMOSell5,000$32.98$164,900.00View SEC Filing  
8/12/2013Kimberly PopovitsCEOSell2,500$33.03$82,575.00View SEC Filing  
8/9/2013Dean SchornoCFOSell4,000$33.15$132,600.00View SEC Filing  
8/7/2013G Bradley ColeCOOSell2,500$33.66$84,150.00View SEC Filing  
7/23/2013Steven ShakCMOSell5,000$35.33$176,650.00View SEC Filing  
7/12/2013Kimberly J PopovitsCEOSell5,000$34.61$173,050.00View SEC Filing  
7/9/2013Dean L SchornoCFOSell4,000$33.81$135,240.00View SEC Filing  
7/8/2013G Bradley ColeCOOSell2,500$33.33$83,325.00View SEC Filing  
6/18/2013Steven ShakCMOSell5,000$33.52$167,600.00View SEC Filing  
6/12/2013Kimberly J PopovitsCEOSell5,000$35.68$178,400.00View SEC Filing  
6/10/2013Dean L SchornoCFOSell4,000$35.88$143,520.00View SEC Filing  
6/5/2013Felix BakerDirectorBuy381,432$36.16$13,792,581.12View SEC Filing  
6/5/2013G Bradley ColeCOOSell2,500$36.47$91,175.00View SEC Filing  
6/3/2013Felix BakerDirectorBuy179,583$36.71$6,592,491.93View SEC Filing  
5/29/2013Felix BakerDirectorBuy121,266$36.89$4,473,502.74View SEC Filing  
5/24/2013Felix BakerDirectorBuy79,417$36.93$2,932,869.81View SEC Filing  
5/22/2013Kathy L HibbsSVPSell1,000$37.48$37,480.00View SEC Filing  
5/21/2013Steven ShakCMOSell5,000$37.19$185,950.00View SEC Filing  
5/16/2013Felix BakerDirectorBuy71,439$36.45$2,603,951.55View SEC Filing  
5/15/2013Randall S LivingstonDirectorSell1,337$35.83$47,904.71View SEC Filing  
5/14/2013Felix BakerDirectorBuy240,426$34.34$8,256,228.84View SEC Filing  
5/13/2013Kathy L HibbsSVPSell1,250$34.42$43,025.00View SEC Filing  
5/13/2013Kimberly J PopovitsCEOSell5,000$34.70$173,500.00View SEC Filing  
5/9/2013Dean L SchornoCFOSell4,000$36.02$144,080.00View SEC Filing  
5/8/2013G Bradley ColeCOOSell2,500$35.99$89,975.00View SEC Filing  
2/21/2013Felix BakerDirectorBuy49,085$27.78$1,363,581.30View SEC Filing  
2/14/2013Woodrow A Myers JrDirectorSell41,250$28.40$1,171,500.00View SEC Filing  
2/11/2013Felix BakerDirectorBuy116,360$28.15$3,275,534.00View SEC Filing  
11/26/2012Randall S LivingstonDirectorSell2,000$27.84$55,680.00View SEC Filing  
11/21/2012Felix BakerDirectorBuy229,300$26.83$6,152,119.00View SEC Filing  
11/14/2012Felix BakerDirectorBuy103,167$27.32$2,818,522.44View SEC Filing  
11/13/2012Felix BakerDirectorBuy823,772$27.81$22,909,099.32View SEC Filing  
11/12/2012Dean L SchornoCFOSell3,000$28.00$84,000.00View SEC Filing  
11/8/2012G Bradley ColeCOOSell2,500$28.62$71,550.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Genomic Health (NASDAQ:GHDX)
DateHeadline logoWill Genomic Health, Inc. (NASDAQ:GHDX) Hit $39.5 Price Target? - Investor Newswire (NASDAQ:GHDX) - August 21 at 9:39 AM logoInsiders Sell Alphabet, Facebook (NASDAQ:GHDX) - August 19 at 5:09 PM logoGENOMIC HEALTH INC Financials (NASDAQ:GHDX) - August 18 at 5:14 PM logoETF’s with exposure to Genomic Health, Inc. : August 16, 2016 (NASDAQ:GHDX) - August 16 at 5:25 PM logoGenomic Health, Inc. breached its 50 day moving average in a Bearish Manner : GHDX-US : August 15, 2016 (NASDAQ:GHDX) - August 15 at 11:25 AM logoGenomic Health, Inc. :GHDX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:GHDX) - August 12 at 5:14 PM logoGENOMIC HEALTH INC Files SEC form 10-Q, Quarterly Report (NASDAQ:GHDX) - August 9 at 9:33 PM logoGenomic Health Inc. (GHDX) is Trading Higher on Unusual Volume for August 04 - (NASDAQ:GHDX) - August 6 at 8:04 AM logoGenomic Health Inc. (GHDX) is Trading Lower on Unusual Volume for August 03 - (NASDAQ:GHDX) - August 5 at 8:06 AM logoGenomic Health, Inc. Pushes Toward Profitability (NASDAQ:GHDX) - August 4 at 5:31 PM logoGenomic Health Inc. (GHDX) is Trading Higher on Unusual Volume for August 01 - (NASDAQ:GHDX) - August 3 at 8:06 AM logoGenomic Health reports 2Q loss (NASDAQ:GHDX) - August 3 at 8:06 AM logoEdited Transcript of GHDX earnings conference call or presentation 2-Aug-16 8:30pm GMT (NASDAQ:GHDX) - August 3 at 8:06 AM logoGenomic Health Reports Continued Double-Digit Growth in Announcement of Second Quarter 2016 Financial … (NASDAQ:GHDX) - August 2 at 5:27 PM logoGENOMIC HEALTH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi (NASDAQ:GHDX) - August 2 at 5:27 PM logo4:28 pm Genomic Health reports EPS in-line, revs in-line; guides FY16 EPS in-line, revs in-line (NASDAQ:GHDX) - August 2 at 5:27 PM logoGenomic Health EPS in-line, beats on revenue (NASDAQ:GHDX) - August 2 at 4:28 PM logoQ2 2016 Genomic Health Inc Earnings Release - After Market Close (NASDAQ:GHDX) - August 2 at 10:00 AM logo3 Things to Watch as Genomic Health, Inc. Reports Earnings (NASDAQ:GHDX) - August 1 at 4:36 PM
News IconNotable Insider Trading: Genomic Health, Inc. (NASDAQ:GHDX) - The Voice Registrar (NASDAQ:GHDX) - July 27 at 5:05 AM logoGenomic Health to Announce Second Quarter 2016 Financial Results and Host Conference Call on Tuesday, August 2, 2016 (NASDAQ:GHDX) - July 26 at 8:00 AM logoIs $39.5 Price Target Attainable For Genomic Health, Inc. (NASDAQ:GHDX)? - Investor Newswire (NASDAQ:GHDX) - July 25 at 5:18 PM
News IconCould Genomic Health, Inc. Decline After Today's Huge Increase? - Press Telegraph (NASDAQ:GHDX) - July 22 at 8:08 AM
News IconEquity Roundup: Stock Performance Focus on Genomic Health, Inc. (NASDAQ:GHDX) - Press Telegraph (NASDAQ:GHDX) - July 20 at 8:03 AM
News IconGenomic Health, Inc. (NASDAQ:GHDX) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:GHDX) - July 20 at 8:03 AM
News IconHow Analysts Rated Genomic Health, Inc. (NASDAQ:GHDX) Last Week? - Consumer Eagle (NASDAQ:GHDX) - July 20 at 8:03 AM logoStrong Sell Calls For Genomic Health, Inc. (NASDAQ:GHDX) At 1 - Investor Newswire (NASDAQ:GHDX) - July 17 at 4:49 PM logoNew Broker Ratings For Genomic Health, Inc. (NASDAQ:GHDX) - FTSE News (NASDAQ:GHDX) - July 15 at 8:08 AM
News IconGenomic Health Incorporated (NASDAQ:GHDX) Shorts Decreased by 4% After Short Covering - Consumer Eagle (NASDAQ:GHDX) - July 15 at 8:08 AM
News IconCrowd Rating and Earnings Recap for Genomic Health, Inc. (NASDAQ:GHDX) - Telanagana Press (NASDAQ:GHDX) - July 15 at 8:08 AM logoOption Market: Genomic Health Inc Risk Hits An Inflection Point - CML News (NASDAQ:GHDX) - July 15 at 8:08 AM
News IconTrading Performance and Target Watch for Genomic Health, Inc. (NASDAQ:GHDX) - Press Telegraph (NASDAQ:GHDX) - July 13 at 8:05 AM logoGenomic Health, Inc. (NASDAQ:GHDX) Current Analyst Ratings - Fiscal Standard (NASDAQ:GHDX) - July 13 at 8:05 AM
News IconStock on the Rise for the Quarter: Genomic Health Inc. (NASDAQ:GHDX) - Engelwood Daily (NASDAQ:GHDX) - July 11 at 5:16 PM
News IconCompany Stock Focus for Genomic Health, Inc. (NASDAQ:GHDX): Which Way Will Shares Head? - Press Telegraph (NASDAQ:GHDX) - July 11 at 5:16 PM
News IconStock Performance Rundown on: Genomic Health Inc. (NASDAQ:GHDX) - Press Telegraph (NASDAQ:GHDX) - July 11 at 5:16 PM logoGenomic Health to Offer Epic Science's AR-V7 test, Shares Up - Yahoo Finance (NASDAQ:GHDX) - July 11 at 5:16 PM logoGenomic Health to Offer Epic Science's AR-V7 test, Shares Up (NASDAQ:GHDX) - July 11 at 9:58 AM logoIs $39.5 Within Reach For Genomic Health, Inc. (NASDAQ:GHDX)? - Investor Newswire (NASDAQ:GHDX) - July 10 at 4:54 PM
News IconGenomic Health Incorporated (NASDAQ:GHDX) Shorts Decreased by 4% After Short Covering - Engelwood Daily (NASDAQ:GHDX) - July 10 at 4:54 PM logoEarnings Surprise in Focus: Genomic Health, Inc. (NASDAQ:GHDX) - Investor Newswire (NASDAQ:GHDX) - July 8 at 5:11 PM logoGenomic Health and Epic Sciences Announce Strategic Collaboration to Deliver Novel AR-V7 Liquid Biopsy Test to ... - Yahoo Finance (NASDAQ:GHDX) - July 8 at 8:01 AM logoGenomic Health Inc. Stock Momentum Hits Strength - CML News (NASDAQ:GHDX) - July 8 at 8:01 AM logoGenomic Health inks deal with Epic Sciences to commercialize liquid biopsy test for prostate cancer (NASDAQ:GHDX) - July 7 at 8:36 AM
News IconStock Tracking Down This Month; Investor Alert on Genomic Health Inc. (NASDAQ:GHDX) - Engelwood Daily (NASDAQ:GHDX) - July 7 at 8:02 AM
News IconGenomic Health, Inc. (NASDAQ:GHDX) Stock Update: Check on Ratings and Target Price - Telanagana Press (NASDAQ:GHDX) - July 7 at 8:02 AM
News IconStock Rating Watch and Earnings Insight for Genomic Health, Inc. (NASDAQ:GHDX) - Press Telegraph (NASDAQ:GHDX) - July 7 at 8:02 AM logoBroker Outlook For Genomic Health, Inc. (NASDAQ:GHDX) - Fiscal Standard (NASDAQ:GHDX) - July 7 at 8:02 AM logo[$$] Test Aids Prostate Cancer Treatment (NASDAQ:GHDX) - July 7 at 12:11 AM logoGenomic Health, Inc. – Value Analysis (NASDAQ:GHDX) : July 5, 2016 (NASDAQ:GHDX) - July 5 at 12:10 PM


Genomic Health (NASDAQ:GHDX) Chart for Wednesday, August, 24, 2016

Last Updated on 8/24/2016 by Staff